 | • レポートコード：QYR2104Z5828 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、尿道炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、抗菌剤、抗ウイルス剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・尿道炎治療薬の市場動向 ・企業の競争状況、市場シェア ・尿道炎治療薬の種類別市場規模（鎮痛剤、抗菌剤、抗ウイルス剤、その他） ・尿道炎治療薬の用途別市場規模（病院、診療所、その他） ・尿道炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・尿道炎治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・尿道炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・尿道炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・尿道炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Teva Pharmaceutical、Johnson & Johnson、Roche、AbbVie、Merck、AstraZeneca、Eli Lilly、Bristol-Myers Squibb、Bayer） ・結論 |
Urethritis is an inflammation of the urethra, or the tube that carries urine. It shows various symptoms such as pain while urinating and an increased urge to urinate. Additionally, burning sensation while urinating, presence of blood in the semen or urine, frequent urge and discomfort while urinating, abnormal discharge from the vagina or penis, etc. are other common symptoms. Other serious manifestation of urethritis include damage to the reproductive system, pelvic inflammatory disease (PID), which can result in infertility, and others.
Females have a greater chance of developing urethritis than males because of the nearness of urethra to the anus, which increases the chance of microbial infection.
Market Analysis and Insights: Global Urethritis Drugs Market
The global Urethritis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Urethritis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Urethritis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Urethritis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Urethritis Drugs market.
Global Urethritis Drugs Scope and Market Size
Urethritis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Urethritis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pain Killers
Anti-Bacterial
Antiviral
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
Teva Pharmaceutical
Johnson & Johnson
Roche
AbbVie
Merck
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urethritis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pain Killers
1.2.3 Anti-Bacterial
1.2.4 Antiviral
1.2.5 Others
1.3 Market by Application
1.3.1 Global Urethritis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Urethritis Drugs Market Perspective (2016-2027)
2.2 Urethritis Drugs Growth Trends by Regions
2.2.1 Urethritis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Urethritis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Urethritis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Urethritis Drugs Industry Dynamic
2.3.1 Urethritis Drugs Market Trends
2.3.2 Urethritis Drugs Market Drivers
2.3.3 Urethritis Drugs Market Challenges
2.3.4 Urethritis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urethritis Drugs Players by Revenue
3.1.1 Global Top Urethritis Drugs Players by Revenue (2016-2021)
3.1.2 Global Urethritis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Urethritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Urethritis Drugs Revenue
3.4 Global Urethritis Drugs Market Concentration Ratio
3.4.1 Global Urethritis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urethritis Drugs Revenue in 2020
3.5 Urethritis Drugs Key Players Head office and Area Served
3.6 Key Players Urethritis Drugs Product Solution and Service
3.7 Date of Enter into Urethritis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Urethritis Drugs Breakdown Data by Type
4.1 Global Urethritis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Urethritis Drugs Forecasted Market Size by Type (2022-2027)
5 Urethritis Drugs Breakdown Data by Application
5.1 Global Urethritis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Urethritis Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Urethritis Drugs Market Size (2016-2027)
6.2 North America Urethritis Drugs Market Size by Type
6.2.1 North America Urethritis Drugs Market Size by Type (2016-2021)
6.2.2 North America Urethritis Drugs Market Size by Type (2022-2027)
6.2.3 North America Urethritis Drugs Market Size by Type (2016-2027)
6.3 North America Urethritis Drugs Market Size by Application
6.3.1 North America Urethritis Drugs Market Size by Application (2016-2021)
6.3.2 North America Urethritis Drugs Market Size by Application (2022-2027)
6.3.3 North America Urethritis Drugs Market Size by Application (2016-2027)
6.4 North America Urethritis Drugs Market Size by Country
6.4.1 North America Urethritis Drugs Market Size by Country (2016-2021)
6.4.2 North America Urethritis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Urethritis Drugs Market Size (2016-2027)
7.2 Europe Urethritis Drugs Market Size by Type
7.2.1 Europe Urethritis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Urethritis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Urethritis Drugs Market Size by Type (2016-2027)
7.3 Europe Urethritis Drugs Market Size by Application
7.3.1 Europe Urethritis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Urethritis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Urethritis Drugs Market Size by Application (2016-2027)
7.4 Europe Urethritis Drugs Market Size by Country
7.4.1 Europe Urethritis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Urethritis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Urethritis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Urethritis Drugs Market Size by Type
8.2.1 Asia-Pacific Urethritis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Urethritis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Urethritis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Urethritis Drugs Market Size by Application
8.3.1 Asia-Pacific Urethritis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Urethritis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Urethritis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Urethritis Drugs Market Size by Region
8.4.1 Asia-Pacific Urethritis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Urethritis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Urethritis Drugs Market Size (2016-2027)
9.2 Latin America Urethritis Drugs Market Size by Type
9.2.1 Latin America Urethritis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Urethritis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Urethritis Drugs Market Size by Type (2016-2027)
9.3 Latin America Urethritis Drugs Market Size by Application
9.3.1 Latin America Urethritis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Urethritis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Urethritis Drugs Market Size by Application (2016-2027)
9.4 Latin America Urethritis Drugs Market Size by Country
9.4.1 Latin America Urethritis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Urethritis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urethritis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Urethritis Drugs Market Size by Type
10.2.1 Middle East & Africa Urethritis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Urethritis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Urethritis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Urethritis Drugs Market Size by Application
10.3.1 Middle East & Africa Urethritis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Urethritis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Urethritis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Urethritis Drugs Market Size by Country
10.4.1 Middle East & Africa Urethritis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Urethritis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Urethritis Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Urethritis Drugs Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Urethritis Drugs Introduction
11.2.4 Teva Pharmaceutical Revenue in Urethritis Drugs Business (2016-2021)
11.2.5 Teva Pharmaceutical Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Urethritis Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Urethritis Drugs Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Urethritis Drugs Introduction
11.4.4 Roche Revenue in Urethritis Drugs Business (2016-2021)
11.4.5 Roche Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Urethritis Drugs Introduction
11.5.4 AbbVie Revenue in Urethritis Drugs Business (2016-2021)
11.5.5 AbbVie Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Urethritis Drugs Introduction
11.6.4 Merck Revenue in Urethritis Drugs Business (2016-2021)
11.6.5 Merck Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Urethritis Drugs Introduction
11.7.4 AstraZeneca Revenue in Urethritis Drugs Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Urethritis Drugs Introduction
11.8.4 Eli Lilly Revenue in Urethritis Drugs Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Urethritis Drugs Introduction
11.9.4 Bristol-Myers Squibb Revenue in Urethritis Drugs Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Urethritis Drugs Introduction
11.10.4 Bayer Revenue in Urethritis Drugs Business (2016-2021)
11.10.5 Bayer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Urethritis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pain Killers
Table 3. Key Players of Anti-Bacterial
Table 4. Key Players of Antiviral
Table 5. Key Players of Others
Table 6. Global Urethritis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Urethritis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Urethritis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Urethritis Drugs Market Share by Regions (2016-2021)
Table 10. Global Urethritis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Urethritis Drugs Market Share by Regions (2022-2027)
Table 12. Urethritis Drugs Market Trends
Table 13. Urethritis Drugs Market Drivers
Table 14. Urethritis Drugs Market Challenges
Table 15. Urethritis Drugs Market Restraints
Table 16. Global Urethritis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Urethritis Drugs Market Share by Players (2016-2021)
Table 18. Global Top Urethritis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urethritis Drugs as of 2020)
Table 19. Ranking of Global Top Urethritis Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Urethritis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Urethritis Drugs Product Solution and Service
Table 23. Date of Enter into Urethritis Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Urethritis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Urethritis Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Urethritis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Urethritis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Urethritis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Urethritis Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Urethritis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Urethritis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Urethritis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Urethritis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Urethritis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Urethritis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Urethritis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Urethritis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Urethritis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Urethritis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Urethritis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Urethritis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Urethritis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Urethritis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Urethritis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Urethritis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Urethritis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Urethritis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Urethritis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Urethritis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Urethritis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Urethritis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Urethritis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Urethritis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Urethritis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Urethritis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Urethritis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Urethritis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Urethritis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Urethritis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Urethritis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Urethritis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Urethritis Drugs Product
Table 66. GlaxoSmithKline Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Teva Pharmaceutical Company Details
Table 69. Teva Pharmaceutical Business Overview
Table 70. Teva Pharmaceutical Urethritis Drugs Product
Table 71. Teva Pharmaceutical Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 72. Teva Pharmaceutical Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Urethritis Drugs Product
Table 76. Johnson & Johnson Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Urethritis Drugs Product
Table 81. Roche Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. AbbVie Company Details
Table 84. AbbVie Business Overview
Table 85. AbbVie Urethritis Drugs Product
Table 86. AbbVie Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 87. AbbVie Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Urethritis Drugs Product
Table 91. Merck Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Urethritis Drugs Product
Table 96. AstraZeneca Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 97. AstraZeneca Recent Development
Table 98. Eli Lilly Company Details
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 101. Eli Lilly Recent Development
Table 102. Bristol-Myers Squibb Company Details
Table 103. Bristol-Myers Squibb Business Overview
Table 104. Bristol-Myers Squibb Urethritis Drugs Product
Table 105. Bristol-Myers Squibb Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 106. Bristol-Myers Squibb Recent Development
Table 107. Bayer Company Details
Table 108. Bayer Business Overview
Table 109. Bayer Urethritis Drugs Product
Table 110. Bayer Revenue in Urethritis Drugs Business (2016-2021) & (US$ Million)
Table 111. Bayer Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urethritis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Pain Killers Features
Figure 3. Anti-Bacterial Features
Figure 4. Antiviral Features
Figure 5. Others Features
Figure 6. Global Urethritis Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Urethritis Drugs Report Years Considered
Figure 11. Global Urethritis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Urethritis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Urethritis Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Urethritis Drugs Market Share by Regions (2022-2027)
Figure 15. Global Urethritis Drugs Market Share by Players in 2020
Figure 16. Global Top Urethritis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urethritis Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Urethritis Drugs Revenue in 2020
Figure 18. Global Urethritis Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Urethritis Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Urethritis Drugs Market Share by Type (2016-2027)
Figure 22. North America Urethritis Drugs Market Share by Application (2016-2027)
Figure 23. North America Urethritis Drugs Market Share by Country (2016-2027)
Figure 24. United States Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Urethritis Drugs Market Share by Type (2016-2027)
Figure 28. Europe Urethritis Drugs Market Share by Application (2016-2027)
Figure 29. Europe Urethritis Drugs Market Share by Country (2016-2027)
Figure 30. Germany Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Urethritis Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Urethritis Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Urethritis Drugs Market Share by Region (2016-2027)
Figure 40. China Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Urethritis Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Urethritis Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Urethritis Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Urethritis Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Urethritis Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Urethritis Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Urethritis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Urethritis Drugs Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の尿道炎治療市場規模・現状・予測（2021年-2027年） Urethritis is an inflammation of the urethra, or the tube that carries urine. It shows various symptoms such as pain while urinating and an increased urge to urinate. Additionally, burning sensation while urinating, presence of blood in the semen or urine, frequent urge and discomfort while urinatin…- 世界の神経因性疼痛治療薬市場規模・現状・予測（2021年-2027年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…
- 世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年） Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2…
- 世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年） Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2…
- 世界の抗インフルエンザ薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-influenza Drugs Market The global Anti-influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…